Home › Funds › Hood River Capital Management LLC › KRYS
Hood River Capital Management LLC position in KRYS
KRYSTAL BIOTECH INC · Health Care
Hood River Capital Management LLC reported holding 671,985 shares of KRYS (KRYSTAL BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$223.5M, representing 1.89% of its reported portfolio and ranking #9 among its reported holdings. Hood River Capital Management LLC has disclosed KRYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Hood River Capital Management LLC's KRYS position evolved
Hood River Capital Management LLC first disclosed a stake in KRYS in Q3 2023 at 460,489 shares (US$53.4M). The position peaked in Q2 2026 at 663,375 shares, worth US$246.6M. Across 13 filings, Hood River Capital Management LLC increased the stake 10 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 671,985 shares valued at US$223.5M — an increase of 8,610 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 460.49K | $53.42M | New |
| Q4 2023 | 458.51K | $56.88M | Hold |
| Q1 2024 | 495.59K | $88.18M | Add |
| Q2 2024 | 521.09K | $95.69M | Add |
| Q3 2024 | 502.10K | $91.40M | Reduce |
| Q4 2024 | 512.73K | $80.32M | Add |
| Q1 2025 | 524.64K | $94.59M | Add |
| Q2 2025 | 533.02K | $73.27M | Add |
| Q3 2025 | 606.95K | $107.14M | Add |
| Q4 2025 | 613.30K | $151.20M | Add |
| Q1 2026 | 619.59K | $160.05M | Add |
| Q2 2026 | 663.38K | $246.56M | Add |
| Q3 2026 | 671.99K | $223.48M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KRYS and 13F data
KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 41 other funds we track also report a position in KRYS — the largest reported positions include Avoro Capital Advisors LLC (US$960.7M), Soleus Capital Management, L.P. (US$349.1M), Redmile Group, LLC (US$234.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KRYS
- Avoro Capital Advisors LLC 2.89M sh · $960.73M · Q3 2026
- Soleus Capital Management, L.P. 939.25K sh · $349.09M · Q2 2026
- Redmile Group, LLC 632.00K sh · $234.90M · Q2 2026
- Frazier Life Sciences Management, L.P. 481.31K sh · $178.89M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 520.92K sh · $173.24M · Q3 2026
- BRAIDWELL LP 128.97K sh · $47.94M · Q2 2026
More on Hood River Capital Management LLC
FAQ
How long has Hood River Capital Management LLC held KRYS?
Hood River Capital Management LLC has disclosed KRYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Hood River Capital Management LLC's current position in KRYS?
As of Q3 2026, Hood River Capital Management LLC holds 671.99K shares of KRYS (KRYSTAL BIOTECH INC), valued at $223.48M, representing 1.89% of its reported portfolio and ranking #9.
Has Hood River Capital Management LLC been buying or selling KRYS?
In the latest 13F filing (Q3 2026), Hood River Capital Management LLC increased its position in KRYS. The position peaked in Q2 2026 at 663.38K shares.
Which other funds hold KRYS?
Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Redmile Group, LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.